metabolic syndrome and glp 1 GLP-1 Therapy Part 1: Setting Realistic Weight Loss Expectations – Sarah Hormachea Targeting GLP-1, GIP & GCG

This article thoroughly traces the developmental milestones of GLP-1 drugs, from their initial discovery to their clinical application, detailing the evolution of diverse GLP-1 medications along with their distinct pharmacological properties

I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance)

By the second month, my energy had returned

Survey shows links to lower substance use and better impulse control.

As millions of patients gain access to popular weight-loss medications, physicians and health systems face a growing landscape of liability risks they need to prepare for now.

FDA-approved medications, and who each fits best.